- No File
POSTECH thanks Genexine for donating KRW 250 million won
Genexine made a five-year pledge of 250 million won (USD 226,000) as research funds to POSTECH.
The donation will be used to promote scholarship programs for undergraduate students who take Research Participation or Undergraduate Thesis courses in the Department of Life Sciences.
Genexine, which started as an in-school venture company in 1999, has grown into a company with a market value of 3 trillion won.
Genexine is currently developing COVID-19 vaccines and treatments, along with about 10 other new drug candidate materials. POSTECH believes that Genexine's efforts will help save humanity from various threats.